{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:32:48Z","timestamp":1774989168780,"version":"3.50.1"},"reference-count":60,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T00:00:00Z","timestamp":1473897600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>The <jats:italic>Diagnostic and Statistical Manual of Mental Disorders<\/jats:italic>, Fifth Edition (DSM-5) mixed features specifier provides a less restrictive definition of mixed mood states, compared to the <jats:italic>Diagnostic and Statistical Manual of Mental Disorders<\/jats:italic>, Fourth Edition, Text Revision (DSM-IV-TR), including mood episodes that manifest with subthreshold symptoms of the opposite mood state. A limited number of studies have assessed the efficacy of treatments specifically for DSM-5\u2013defined mixed features in mood disorders. As such, there is currently an inadequate amount of data to appropriately inform evidence-based treatment guidelines of DSM-5 defined mixed features. However, given the high prevalence and morbidity of mixed features, treatment recommendations based on the currently available evidence along with expert opinion may be of benefit. This article serves to provide these interim treatment recommendations while humbly acknowledging the limited amount of evidence currently available. Second-generation antipsychotics (SGAs) appear to have the greatest promise in the treatment of bipolar disorder (BD) with mixed features. Conventional mood stabilizing agents (ie, lithium and divalproex) may also be of benefit; however, they have been inadequately studied. In the treatment of major depressive disorder (MDD) with mixed features, the comparable efficacy of antidepressants versus other treatments, such as SGAs, remains unknown. As such, antidepressants remain first-line treatment of MDD with or without mixed features; however, there are significant safety concerns associated with antidepressant monotherapy when mixed features are present, which merits increased monitoring. Lurasidone is the only SGA monotherapy that has been shown to be efficacious specifically in the treatment of MDD with mixed features. Further research is needed to accurately determine the efficacy, safety, and tolerability of treatments specifically for mood episodes with mixed features to adequately inform future treatment guidelines.<\/jats:p>","DOI":"10.1017\/s1092852916000432","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T03:34:51Z","timestamp":1473910491000},"page":"147-154","source":"Crossref","is-referenced-by-count":17,"title":["Treatment recommendations for DSM-5\u2013defined mixed features"],"prefix":"10.1017","volume":"22","author":[{"given":"Joshua D.","family":"Rosenblat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"S1092852916000432_ref25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09293"},{"key":"S1092852916000432_ref10","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07041"},{"key":"S1092852916000432_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2007.01131.x"},{"key":"S1092852916000432_ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-008-5009-z"},{"key":"S1092852916000432_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.05.077"},{"key":"S1092852916000432_ref52","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000144887.66319.2f"},{"key":"S1092852916000432_ref41","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2535"},{"key":"S1092852916000432_ref15","first-page":"493","article-title":"Korean Medication Algorithm Project for Bipolar Disorder: third revision","volume":"11","author":"Woo","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"S1092852916000432_ref28","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0504"},{"key":"S1092852916000432_ref14","unstructured":"2015 Florida Best Practice Psychotherapeutic Medication Guidelines for Adults. 2015. http:\/\/medicaidmentalhealth.org\/ViewGuideline.cfm?GuidelineID=97."},{"key":"S1092852916000432_ref57","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08634"},{"key":"S1092852916000432_ref20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.113548"},{"key":"S1092852916000432_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.06.039"},{"key":"S1092852916000432_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00330-0"},{"key":"S1092852916000432_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.09.026"},{"key":"S1092852916000432_ref45","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09181"},{"key":"S1092852916000432_ref60","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000229"},{"key":"S1092852916000432_ref43","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020164"},{"key":"S1092852916000432_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2015.12.005"},{"key":"S1092852916000432_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.025"},{"key":"S1092852916000432_ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2012.00990.x"},{"key":"S1092852916000432_ref49","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04772gre"},{"key":"S1092852916000432_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.041"},{"key":"S1092852916000432_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.09.035"},{"key":"S1092852916000432_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12025"},{"key":"S1092852916000432_ref55","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15060770"},{"key":"S1092852916000432_ref59","first-page":"28","article-title":"Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder","volume":"66","author":"McIntyre","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"S1092852916000432_ref2","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000029"},{"key":"S1092852916000432_ref37","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001817"},{"key":"S1092852916000432_ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415594428"},{"key":"S1092852916000432_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.04.003"},{"key":"S1092852916000432_ref48","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-0031-1297984","article-title":"Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state","volume":"45","author":"Pae","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"S1092852916000432_ref39","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.08030322"},{"key":"S1092852916000432_ref4","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v5.i1.126"},{"key":"S1092852916000432_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00317-8"},{"key":"S1092852916000432_ref5","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"S1092852916000432_ref38","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.232"},{"key":"S1092852916000432_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.10.011"},{"key":"S1092852916000432_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.10.061"},{"key":"S1092852916000432_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.04.032"},{"key":"S1092852916000432_ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034757"},{"key":"S1092852916000432_ref24","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715000446"},{"key":"S1092852916000432_ref34","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04854yel"},{"key":"S1092852916000432_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12338"},{"key":"S1092852916000432_ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0275-6"},{"key":"S1092852916000432_ref44","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09081"},{"key":"S1092852916000432_ref53","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1351"},{"key":"S1092852916000432_ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/757258"},{"key":"S1092852916000432_ref19","doi-asserted-by":"publisher","DOI":"10.1186\/2194-7511-1-21"},{"key":"S1092852916000432_ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.10.040"},{"key":"S1092852916000432_ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2012.12030301"},{"key":"S1092852916000432_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.02.031"},{"key":"S1092852916000432_ref3","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"S1092852916000432_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.04.026"},{"key":"S1092852916000432_ref40","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000406"},{"key":"S1092852916000432_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2015.09.005"},{"key":"S1092852916000432_ref51","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09410"},{"key":"S1092852916000432_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60453-X"},{"key":"S1092852916000432_ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.527"},{"key":"S1092852916000432_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.04.012"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852916000432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T21:51:19Z","timestamp":1555537879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852916000432\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1092852916000432"],"URL":"https:\/\/doi.org\/10.1017\/s1092852916000432","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}